- Home
- FSM vs ARQT Comparison
FSM vs ARQT Comparison
Compare FSM & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSM | ARQT |
|---|---|---|
| Founded | 1990 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.3B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | FSM | ARQT |
|---|---|---|
| Price | $9.48 | $29.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $11.00 | ★ $24.83 |
| AVG Volume (30 Days) | ★ 7.0M | 2.4M |
| Earning Date | 11-05-2025 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 809.52 | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $1,256,829,000.00 | $317,929,000.00 |
| Revenue This Year | $0.28 | $85.51 |
| Revenue Next Year | $11.64 | $30.74 |
| P/E Ratio | $13.21 | ★ N/A |
| Revenue Growth | 68.17 | ★ 129.21 |
| 52 Week Low | $4.13 | $11.13 |
| 52 Week High | $10.38 | $31.77 |
Technical Indicators
Market Signals| Indicator | FSM | ARQT |
|---|---|---|
| Relative Strength Index (RSI) | 56.99 | 56.09 |
| Support Level | $9.17 | $28.30 |
| Resistance Level | $10.08 | $31.77 |
| Average True Range (ATR) | 0.42 | 1.08 |
| MACD | 0.00 | -0.43 |
| Stochastic Oscillator | 35.07 | 22.77 |
Price Performance
Historical ComparisonAbout FSM Fortuna Silver Mines Inc (Canada)
Fortuna Mining Corp is a Canadian-based precious metals mining company with mines in the Latin America and West Africa regions producing gold and silver. It operate mines in Argentina, Burkina Faso, Cote d'Ivoire, Mexico, and Peru. The company's segment consists of Mansfield, Sanu, Sango, Cuzcatlan, Bateas, Corporate. The company generates the majority of its revenue from Sango segment which operates the Seguela gold mine. Geographically, the company generates the majority of its revenue from Cote d'Ivoire location.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.